Parkinson's Disease Trial, Recruiting NCT07058285 Sponsor: University of Kiel Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07058285
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease according to a specific set of recognised medical guidelines (the MDS Criteria)
  • People whose Parkinson's disease is at a mild to moderate stage (Hoehn and Yahr stages I to III)
  • People who have at least some difficulty with walking as measured by a standard Parkinson's disease assessment tool
  • People who have given their written agreement to take part in the trial

Who may not be able to join:

  • People with a known health condition that would make unsupervised physical exercise unsafe or unsuitable for them
  • People experiencing moderate or severe depression, as measured by a standard questionnaire score of 18 or above on the BDI-II scale
  • People whose thinking or memory difficulties may prevent them from fully understanding and agreeing to take part
  • People who have difficulty understanding everyday conversation (less than 75% comprehension)
  • People with a serious psychiatric condition that may make it difficult to follow the trial's requirements
  • People with a current or past dependency on alcohol or other substances
  • People who are unable to walk at least one flight of stairs (confirm with trial site)
  • People who have experienced chest pain in the past four weeks
  • People who are currently taking part in another interventional research study
  • People who have a deep brain stimulation device surgically implanted

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0049 431 500-23981

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Kiel
Registry
ClinicalTrials.gov
Start date
25 July 2024
Est. completion
30 March 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Gait speed - T0; Gait speed - T1; Gait speed - T2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov